Self-Healing Hydrogels Powered by Cyclodextrins Show Promise for Advanced Wound Care

A new generation of wound-healing materials built on cyclodextrin chemistry is advancing rapidly toward clinical use. Recent research examines how beta-cyclodextrin’s unique host-guest chemistry enables the creation of self-healing hydrogels — materials that can autonomously repair themselves after damage, much like living tissue.

These smart biomaterials maintain the moist environment essential for wound healing while providing stimulus-responsive drug release. When applied to a wound, cyclodextrin-based hydrogels can encapsulate and gradually release antimicrobial agents, growth factors, or anti-inflammatory drugs in response to changes in pH or temperature at the wound site.

Particularly promising are injectable formulations that combine oxidized cyclodextrin with chitosan, creating double-network hydrogels that conform to irregular wound shapes. In diabetic wound models, cyclodextrin hydrogels promoting continuous nitric oxide release significantly accelerated healing by enhancing blood vessel formation and collagen deposition.

As antibiotic resistance grows, researchers note that cyclodextrin-chitosan composites also demonstrate inherent antibacterial properties, offering a dual-action approach to chronic wound management.